Journal of the American Academy of Child & Adolescent Psychiatry
Volume 48, Issue 5 , Pages 519-532 , May 2009

A Double-Blind, Randomized, Placebo-Controlled Trial of Divalproex Extended-Release in the Treatment of Bipolar Disorder in Children and Adolescents

,Accepted 29 December 2008.

References 

  1. Geller B , Tillman R , Craney JL , Bolhofner K . Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype . Arch Gen Psychiatry . 2004;61:459–467
  2. Birmaher B , Axelson D , Strober M , et al.   Clinical course of children and adolescents with bipolar spectrum disorders . Arch Gen Psychiatry . 2006;63:175–183
  3. Goldstein TR , Birmaher B , Axelson D , et al.   History of suicide attempts in pediatric bipolar disorder: factors associated with increased risk . Bipolar Disord . 2005;7:525–535
  4. Leverich GS , Post RM , Keck PE , et al.   The poor prognosis of childhood-onset bipolar disorder . J Pediatr . 2007;150:485–490
  5. Kowatch RA , Suppes T , Carmody TJ , et al.   Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder . J Am Acad Child Adolesc Psychiatry . 2000;39:713–720
  6. Wagner KD , Weller EB , Carlson GA , et al.   An open-label trial of divalproex in children and adolescents with bipolar disorder . J Am Acad Child Adolesc Psychiatry . 2002;41:1224–1230
  7. Henry CA , Zamvil LS , Lam C , Rosenquist KJ , Ghaemi SN . Long-term outcome with divalproex in children and adolescents with bipolar disorder . J Child Adolesc Psychopharmacol . 2003;13:523–529
  8. Pavuluri MN , Henry DB , Carbray JA , Sampson G , Naylor MW , Janicak PG . Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania . J Affect Disord . 2004;82(Suppl 1):S103–S111
  9. DelBello MP , Kowatch RA , Adler CM , Stanford KE , et al.   A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania . J Am Acad Child Adolesc Psychiatry . 2006;45:305–313
  10. American Psychiatric Association  . Diagnostic and Statistical Manual for Mental Disorders, Fourth Edition, Text Revision . Washington: American Psychiatric Association; 2000;
  11. Geller B , Warner K , Williams M , Zimerman B . Prepubertal and young adolescent bipolarity versus ADHD: assessment and validity using the WASH-U-KSADS, CBCL and TRF . J Affect Disord . 1998;51:93–100
  12. Geller B , Zimerman B , Williams M , et al.   Reliability of the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) Mania and Rapid Cycling Sections . J Am Acad Child Adolesc Psychiatry . 2001;40:450–455
  13. Young RC , Biggs JT , Ziegler VE , Meyer DA . A rating scale for mania: reliability, validity, and sensitivity . Br J Psychiatry . 1978;133:429–435
  14. Fristad MA , Weller EB , Weller RA . “The Mania Rating Scale: can it be used in 18 children?” . J Am Acad Child Adolesc Psychiatry . 1992;31:252–257
  15. In:  Guy W editors. Clinical Global Impressions in Early Clinical Drug Evaluation Unit 20. Assessment Manual for Psychopharmacology . Rockville: U.S. National Institute of Mental Health; 1976;p. 76–338 : DHEW Publication No. [ADM];
  16. Poznanski EO , Grossman JA , Buchsbaum Y , Banegas M , Freeman L , Gibbons R . Preliminary studies of the reliability and validity of the Children's Depression Rating Scale . J Am Acad Child Psychiatry . 1984;23:191–197
  17. Poznanski EO , Mokros HB . Children's Depression Rating Scale Revised . Los Angeles: Western Psychological Services; 1999;
  18. Brannan AM , Heflinger CA , Bickman L . “The Caregiver Strain Questionnaire: measuring the impact on the family of living with a child with serious emotional disturbance” . J Emot Behav Disord . 1997;5:212–222
  19. Shaffer D , Gould MS , Brasic J , et al.   A Children's Global Assessment Scale (CGAS) . Arch Gen Psychiatry . 1983;40:1228–1231
  20. DuPaul GJ , Power TJ , Anastopoulos AD , Reid R . ADHD Rating Scale IV: 33. Checklists, Norms, and Clinical Interpretations . New York: The Guilford Press; 1998;
  21. Medical Dictionary for Regulatory Activities (MedDRA®) Version 9.0, MedDRA MSSO, c/o of TRW, VAR1/8A/MSSO, 12011 Sunset Hills Road, Reston, VA 20190–3285, USA.
  22. Bowden CL , Swann AC , Calabrese JR , et al.   A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania . J Clin Psychiatry . 2006;67:1501–1510
  23. Gerstner T , Teich M , Bell N , et al.   Valproate-associated coagulopathies are frequent and variable in children . Epilepsia . 2006;47:1136–1143
  24. Koenig S , Gerstner T , Keller A , et al.   High incidence of valproate-induced coagulation disorders in children receiving valproic acid: a prospective study . Blood Coagul Fibrinolysis . 2008;19:375–382
  25. Attilakos A , Katsarou E , Voudris K , Garoufi A . Valproate-associated coagulopathies are frequent and variable in children . Epilepsia . 2007;48:205–206
  26. Acharya S , Bussel JB . Hematologic toxicity of sodium valproate . J Pediatr Hematol Oncol . 2000;22:62–65
  27. Depakote ER . [package insert] . North Chicago: Abbott Laboratories; 2008;
  28. Correll CU . Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials . J Am Acad Child Adolesc Psychiatry . 2007;46:687–700 Review.
  29. Maranda B , Cousineau J , Allard P , Lambert M . False positives in plasma ammonia measurement and their clinical impact in a pediatric population . Clin Biochem . 2007;40:531–535
  30. Urea Cycle Disorders Conference Group  . Consensus statement from a conference for the management of patients with urea cycle disorders . J Pediatr . 2001;138:S1–S5
  31. Wyllie E , Wyllie R , Rothner A , et al.   Valproate-induced hyperammonemia in asymptomatic children . Cleve Clin Q . 1983;50:275–277
  32. Apostol G , Cady R , Laforet G , et al.   Divalproex extended-release in adolescent migraine prophylaxis: results of a randomized, double-blind, placebo-controlled study . Headache . 2008;48:1012–1025
  33. Rasgon N . The relationship between polycystic ovary syndrome and antiepileptic drugs: a review of the evidence . J Clin Psychopharmacol . 2004;24:322–334
  34. United States Food and Drug Administration, Center for Drug Evaluation and Research. Statistical Review and Evaluation. Antiepileptic Drugs and Suicidality . http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008-4372b1-01-FDA.pdf. Accessed July 14, 2008.
  35. United States Food and Drug Administration, Center for Drug Evaluation and Research. Information for Healthcare Professionals: Suicidality and Antiepileptic Drugs. 1/31/2008 . http://www.fda.gov/cder/drug/InfoSheets/HCP/antiepilepticsHCP.htm. Accessed February 5, 2008.
  36. DelBello MP , Findling RL , Kushner S , et al.   A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder . J Am Acad Child Adolesc Psychiatry . 2005;44:539–547
  37. Wagner KD , Kowatch RA , Emslie GJ , et al.   A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents . Am J Psychiatry . 2006;163:1179–1186 Erratum in: Am J Psychiatry. 2006;163:1843.
  38. Tohen M , Kryzhanovskaya L , Carlson G , et al.   Olanzapine versus placebo in the treatment of adolescents with bipolar mania . Am J Psychiatry . 2007;164:1547–1556
  39. Pandina G, DelBello M, Kushner S et al. Risperidone for the Treatment of Acute Mania in Bipolar Youth. Paper presented at the 54th Annual Meeting of the American Academy of Child and Adolescent Psychiatry;October 2007; Boston, MA.
  40. DelBello M, Findling R, Earley W et al. Efficacy of Quetiapine in Children and Adolescents With Bipolar Mania: A 3-Week, Double-Blind, Randomized, Placebo-Controlled Trial. Paper presented at the 54th Annual Meeting of the American Academy of Child and Adolescent Psychiatry; October 2007; Boston, MA.
  41. Chang K, Nyllas M, Aurang C et al. Efficacy of Aripiprazole in Children (10–17 Year Old) With Mania. Paper presented at the 54th Annual Meeting of the American Academy of Child and Adolescent Psychiatry; October 2007; Boston, MA.
  42. Bowden C , Brugger A , Swann A , et al.   Efficacy of divalproex vs lithium and placebo in the treatment of mania. The depakote mania study group . JAMA . 1994;271:918–924
  43. Bowden C , Swann A , Calabrese J , et al.   A randomized placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania . J Clin Psychiatry . 2006;67:1501–1510
  44. Pope H , McElroy S , Keck P , et al.   Valproate in the treatment of acute mania . Arch Gen Psychiatry . 1991;48:62–68
  45. Dutta S , Zhang Y , Conway J , et al.   Divalproex-ER pharmacokinetics in older children and adolescents . Pediatr Neurol . 2004;30:330–337
  46. DelBello MP , Hanseman D , Adler CM , Fleck DE , Strakowski SM . Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode . Am J Psychiatry . 2007;164:582–590
  47. Coletti DJ , Leigh E , Gallelli KA , Kafantaris V . Patterns of adherence to treatment in adolescents with bipolar disorder . J Child Adolesc Psychopharmacol . 2005;15:913–917
  48. DelBello MP , Schwiers ML , Rosenberg HL , Strakowski SM . A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania . J Am Acad Child Adolesc Psychiatry . 2002;41:1216–1223
  49. Findling RL , McNamara NK , Gracious BL , et al.   Combination lithium and divalproex sodium in pediatric bipolarity . J Am Acad Child Adolesc Psychiatry . 2003;42:895–901
  50. Kowatch R , Sethuraman J , Hume J , et al.   Combination pharmacotherapy in children and adolescents with bipolar disorder . Biol Psychiatry . 2003;53:978–984
  51. Schatzberg AF . Employing pharmacologic treatment of bipolar disorder to greatest effect . J Clin Psychiatry . 2004;65(suppl 15):15–20
  52. Goodwin FK . Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder . J Clin Psychiatry . 2003;64(suppl 5):18–24
  53. Hirschfeld M , Bowden CI , Gitlin MJ , et al. , The Work Group for the Treatment of Patients with Bipolar Disorder    APA . http://www.psychiatryonline.com/pracGuide/loadGuidelinePdf.aspx?file=Bipolar2ePG_05-15-06 2002;

 This study was supported by a grant from Abbott Laboratories.The authors thank the other members of the Divalproex ER Pediatric Mania Group, as follows, for their enrollment of patients and participation in this study (both the double-blind and long-term studies unless otherwise indicated): Grant Belnap, M.D., Eagle, ID (long-term study only); Deborah Bergen, M.D., Wichita, KS; Guy Brannon, M.D., Shreveport, LA; Michael Greenbaum, M.D., Libertyville, IL; Sanjay Gupta, M.D., Olean, NY; Robert Hendren, D.O., Sacramento, CA (double-blind study only); Willis Holloway Jr., M.D., Oklahoma City, OK; Ali Kashfi, M.D., P.A., Altamonte Springs, FL; Bennett Leventhal, M.D., Chicago, IL (double-blind study only); Melisa Martinez, M.D., Galveston, TX; Sohail Punjwani, M.D., North Miami, FL; Robert Riesenberg, M.D., Atlanta, GA (double-blind study only); Michael Rieser, M.D., Lexington, KY; Adelaide Robb, M.D., Washington, DC; Franco Sicuro, M.D., St. Louis, MO; Deborah Simkin, M.D., Destin, FL; and William Terry, M.D., Boise, ID (double-blind study only).Clinical trial registration information–An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder in Children and Adolescents. URL: http://clinicaltrials.gov. Unique identifier: NCT00067262. Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associate With Disorder in Children and Adolescents. URL: http://clinicaltrials.gov. Unique identifier: NCT00195767.

PII: S0890-8567(09)60069-1

doi: 10.1097/CHI.0b013e31819c55ec

Journal of the American Academy of Child & Adolescent Psychiatry
Volume 48, Issue 5 , Pages 519-532 , May 2009

Article Tools

* Image Usage & Resolution